NAD+ in Skincare
NAD+ is an emerging skin-conditioning ingredient used in longevity-focused skincare. Current anti-aging evidence relies mainly on laboratory, ex vivo, advanced-delivery, and microneedling research rather than ordinary leave-on use.
- Aliases
- Nicotinamide Adenine Dinucleotide, Beta-Nicotinamide Adenine Dinucleotide, beta-NAD, Nadide
- Ingredient category
- Conditioning Agent
- Most relevant for
- Fine Lines and Wrinkles
- Evidence strength
- Indirect Evidence for Improving visible signs of skin aging with ordinary leave-on NAD+ skincare
- Formula matters
- Stability and skin delivery are major limitations; the delivery system, packaging, concentration, and finished formula matter more than the NAD+ name or percentage alone.
- Separate product needed?
- Usually No. You do not need a dedicated NAD+ serum unless its finished formula has credible human product testing and fills a real gap in your routine.
BB takeaway
NAD+ is biologically interesting but not yet a proven topical longevity treatment. Choose the complete formula rather than paying extra for cellular-aging claims without evidence from the finished product.
Ingredient evidence does not prove the performance of every finished product containing it.
What is NAD+?
NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a coenzyme involved in cellular energy metabolism and many enzyme systems. Recognized names include beta-nicotinamide adenine dinucleotide, beta-NAD, and Nadide.[1]
In cosmetic ingredient lists, it appears as Nicotinamide Adenine Dinucleotide. Health Canada’s ingredient database identifies topical nicotinamide adenine dinucleotide as a skin-conditioning agent.[2]
NAD+ is not the same as niacinamide, nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), or NADH. Those compounds are related to NAD metabolism but have different identities, properties, and evidence.
What does NAD+ do for skin?
In cosmetics, NAD+ is best treated as a skin-conditioning ingredient with an emerging research story around skin aging.
Human skin research shows that tissue NAD+ levels decline with age.[3] That helps explain why NAD+ is being studied for aging skin, but it does not prove that applying NAD+ to intact skin restores youthful cellular function or visibly reverses aging.
Brands commonly connect topical NAD+ with fine lines, firmness, radiance, pigmentation, DNA repair, and “cellular energy.” Those stronger appearance and structure claims still need evidence from the finished product rather than NAD+ biology alone.
NAD+ is not a sunscreen filter, exfoliant, retinoid, established pigment treatment, or proven collagen-building cosmetic active.
What the evidence says about NAD+ skincare
The science is interesting, but the evidence for an ordinary leave-on NAD+ serum is still indirect.
A 2012 study analyzed human skin from 49 people and found that tissue NAD+ levels declined with age.[3] That supports the aging biology behind NAD+, but it did not test topical NAD+ or show improvements in wrinkles, firmness, or pigmentation.
A 2025 experimental study compared free NAD+ with a liposomal formulation in human cells and ex vivo skin. The liposomal system improved measured skin penetration by about 30% and changed several laboratory markers associated with senescence.[4] It did not test visible results in people using a cosmetic serum.
A 2026 study tested an ion-coupled transfersome system designed to improve NAD+ stability and delivery. It reported stronger delivery in porcine and human skin explants and changes in senescence-related molecular signatures.[5] That is promising delivery research, not a consumer anti-aging trial.
The main human topical report published in 2026 used a very different delivery method from ordinary skincare. Thirty-six Korean women with melasma received five microneedling sessions followed immediately by sterile NAD+ application. Melasma scores improved over 21 weeks, but there was no placebo, vehicle, untreated, or microneedling-only control group.[6]
Because microneedling deliberately disrupts the skin barrier, that study cannot be used as evidence that a standard NAD+ serum on intact skin treats melasma or dark spots.
For your routine, the evidence supports emerging technology with better delivery research, not a proven topical longevity treatment.
How NAD+ form and formulation affect results
Delivery is the central formulation issue with topical NAD+.
NAD+ is a relatively large, highly polar molecule, so passive delivery through intact skin is challenging. Recent research therefore focuses on liposomes, transfersomes, and other systems intended to improve stability and skin access.[4][5]
A product listing Nicotinamide Adenine Dinucleotide tells you NAD+ is present. It does not tell you how stable the ingredient remains, how much reaches relevant skin layers, or whether the finished product improves a visible outcome.
Related NAD-pathway ingredients should not be treated as interchangeable. Niacinamide has a much larger topical skincare evidence base. NMN and NR are NAD+ precursors with different molecular properties. NADH is the reduced form of nicotinamide adenine dinucleotide. A proprietary “NAD-boosting” complex may contain no NAD+ at all.
Percentage claims are also weak shortcuts unless the brand explains exactly what the number represents and supports the finished formula. A high NAD+ percentage does not overcome poor stability or poor delivery.
Who may benefit from NAD+ skincare?
NAD+ skincare is most relevant if you enjoy trying emerging aging-focused formulas and are comfortable with uncertainty around the ingredient’s visible benefits.
It makes more sense when the complete product already does something useful—such as moisturizing—and the brand provides credible testing on the finished formula.
It makes less sense when you are buying it specifically to treat wrinkles, firmness loss, melasma, or dark spots. Those concerns have better-supported topical options.
If visible photoaging is your priority, retinoids have much stronger direct human evidence. For uneven tone or barrier support, established ingredients such as niacinamide or vitamin C may be more straightforward depending on the formula and concern.
NAD+ side effects and irritation risk
There is not enough routine leave-on clinical research to define a characteristic irritation profile for topical NAD+ with the same confidence available for long-established skincare ingredients.
Health Canada lists topical nicotinamide adenine dinucleotide as a non-medicinal skin-conditioning agent, but that designation is not proof that every concentration, delivery system, or finished product is non-irritating.[2]
Fragrance, solvents, preservatives, exfoliating acids, retinoids, vitamin C derivatives, delivery agents, or other ingredients in an NAD+ formula may contribute more to irritation than NAD+ itself.
The lack of a well-defined NAD+ irritation pattern should not be mistaken for proof of zero risk. Stop using a product that causes persistent burning, swelling, severe itching, blistering, or a worsening rash.
Microneedling-assisted or sterile NAD+ skin-booster procedures are not equivalent to cosmetic leave-on use and should not be recreated at home from skincare instructions.
How to use NAD+ in your skincare routine
Follow the directions for the exact finished product.
A lightweight NAD+ serum generally goes after cleansing and before moisturizer. A cream containing NAD+ can simply serve as the moisturizing step if it meets your skin’s needs.
There is no established reason to layer several NAD+ products or to add a separate “NAD-boosting” step to a direct NAD+ serum.
NAD+ can fit into routines with niacinamide, peptides, vitamin C, or retinoids when the finished products are compatible and comfortable. If a brand gives specific stability or layering instructions, follow those directions.
During the day, broad-spectrum sunscreen remains the more important step for preventing visible photoaging.
How long does NAD+ take to work?
There is no dependable timeline for visible results from an ordinary topical NAD+ cosmetic.
Laboratory studies can detect changes in penetration or cellular markers over short experimental periods, but those measurements do not translate into a guaranteed wrinkle, firmness, or pigmentation timeline for a retail serum.
The 2026 melasma case series assessed its microneedling-assisted procedure over 21 weeks, but that does not establish a timeline for intact-skin use.[6]
If a product makes skin look smoother or more hydrated immediately, the moisturizer base, humectants, silicones, or film-forming ingredients may be responsible. Strong four-, eight-, or twelve-week anti-aging claims should be backed by finished-product testing.
What can you use with NAD+?
NAD+ can generally sit alongside common skincare ingredients because there is no established universal incompatibility rule for topical cosmetic use.
For better-supported aging care, it can sit alongside retinoids. For barrier support or uneven tone, niacinamide may be useful. Vitamin C can add antioxidant and brightening support, while peptides may appeal in non-exfoliating aging-focused formulas. Ceramides and glycerin remain useful when dryness is part of the problem.
The practical limit is the complete routine’s tolerability and the stability instructions for the products you use.
How to choose an NAD+ product
Start by checking whether the product actually contains Nicotinamide Adenine Dinucleotide.
Do not assume “NAD technology,” “NAD support,” “cellular energy complex,” or “longevity blend” means the product contains NAD+ itself.
Then ask whether the finished formula earns its claim:
- Is the product tested on people using it on intact skin?
- Does the brand explain the delivery system rather than relying only on cellular-aging language?
- Does any highlighted percentage clearly refer to NAD+ itself?
- Are visible results measured against a control or comparison product?
- Are better-established ingredients likely to be doing much of the visible work?
- Would a less expensive formula address the same concern with stronger evidence?
Be particularly cautious with claims such as “repairs DNA,” “reverses cellular aging,” “restores youthful cell function,” or “boosts collagen production.” In the United States, FDA explains that products marketed to affect the structure or function of the body, including the skin, can meet the legal definition of a drug rather than a cosmetic.[7]
NAD+ alone does not justify Premium pricing. Pay more only when the complete formula provides a meaningful advantage in delivery, testing, stability, texture, packaging, tolerability, or overall performance.
Do you need a separate NAD+ serum?
Usually, no.
A dedicated NAD+ serum can make sense if you specifically want to try an emerging longevity-focused ingredient, the formula has credible finished-product evidence, and it fills a real gap in your routine.
Skip it when the product mainly sells a cellular-aging story, when you already have a well-supported treatment for the same goal, or when the price premium depends more on NAD+ marketing than on product-level proof.
For your routine, NAD+ is an optional feature in a good formula, not a foundational requirement.
The BB Perspective
NAD+ is biologically important, and 2025-2026 delivery research makes topical use more plausible than it was a few years ago.
What is still missing is the part shoppers need most: well-controlled human evidence showing that an ordinary leave-on NAD+ product meaningfully improves wrinkles, firmness, pigmentation, or other visible concerns on intact skin.
That is why NAD+ should currently be treated as an emerging skin-conditioning ingredient. Choose the complete formula, demand human product-level evidence for strong claims, and do not pay a longevity premium for biology that has not yet translated into proven cosmetic results.
Last reviewed: September 2026
Sources
National Library of Medicine PubChem. beta-Nicotinamide adenine dinucleotide.
PubChem identifies the oxidized nicotinamide adenine dinucleotide molecule and lists recognized names including beta-nicotinamide adenine dinucleotide, beta-NAD, and related historical names. This source supports identity rather than topical cosmetic efficacy. Return to citation.
Health Canada. Natural Health Products Ingredients Database: Nicotinamide adenine dinucleotide. Current September 2026.
Health Canada’s database lists beta-NAD and Nadide among common or proper names and identifies topical nicotinamide adenine dinucleotide as a non-medicinal skin-conditioning agent. This supports cosmetic identity and function rather than wrinkle, firmness, or pigmentation efficacy. Return to citation.
Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7(7):e42357. doi:10.1371/journal.pone.0042357. PMID:22848760. PMCID:PMC3407129.
This study analyzed human skin samples from 49 people and found that tissue NAD+ levels declined with age. It did not test topical NAD+ or visible skincare outcomes. The study used internal Australasian Research Institute and University of New South Wales funding. Two authors disclosed that they were directors of NADLife, an NAD-focused biotechnology startup. Return to citation.
Ministrini S, Liberale L, Erle HE, et al. A Liposomal Formulation Enhances the Anti-Senescence Properties of Nicotinamide Adenine-Dinucleotide (NAD+) in Endothelial Cells and Keratinocytes. Current Issues in Molecular Biology. 2025;47(9):722. doi:10.3390/cimb47090722. PMID:41020844. PMCID:PMC12468054.
This experimental study compared free NAD+ with a liposomal formulation in primary human cells and ex vivo skin. The liposomal preparation increased measured skin penetration by about 30% and changed laboratory senescence markers, but it did not test visible cosmetic results in people. Sovida Solutions Ltd. funded the article-processing charge; two authors were Sovida employees and one author reported consulting for the company. The paper did not report Sovida as the study funder. Return to citation.
Kang S, Wei S, Koo BI, et al. Ion-coupled transfersome complexes for enhanced transdermal NAD+ repletion and mitigation of cellular senescence signatures. Materials Today Bio. 2026;38:103218. doi:10.1016/j.mtbio.2026.103218. PMID:42170234. PMCID:PMC13188140.
This preclinical study tested a transfersome system intended to stabilize NAD+ and improve skin delivery. It reported enhanced delivery in porcine and human skin explants and changes in senescence-related molecular signatures, but no consumer clinical outcome. The study was supported in part by LG Household & Health Care R&D Center and Korean public research grants; nine authors were employees of LG Household & Health Care R&D Center. Return to citation.
Yi KH, Wan J, Hwang S. Efficacy and Safety of a Topical Nicotinamide Adenine Dinucleotide Skinbooster for the Treatment of Melasma. Aesthetic Plastic Surgery. 2026;50(11):4431-4436. doi:10.1007/s00266-026-05726-1. PMID:41870519.
This prospective single-center case series followed 36 Korean women with mixed-type melasma through five sessions of microneedling followed by sterile NAD+ application. Melasma scores improved over 21 weeks, but there was no placebo, vehicle, untreated, or microneedling-only control. Because the procedure deliberately increased skin delivery, the study does not establish efficacy for an ordinary leave-on NAD+ cosmetic on intact skin. The authors declared no conflicts of interest. Return to citation.
U.S. Food and Drug Administration. Cosmetics Labeling Claims. Current September 2026.
FDA states that cosmetic claims must be truthful and not misleading and that a product marketed to treat or prevent disease or affect the structure or function of the body, including the skin, is a drug under U.S. law. This is relevant to NAD+ marketing that moves from appearance claims into promises about DNA repair, collagen production, or cellular function. The page does not evaluate NAD+ specifically. Return to citation.